Cohn J et al. (2003). “Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)”. Eur J Heart Fail5 (5): 659-67. doi:10.1016/S1388-9842(03)00163-6. PMID14607206.
nih.gov
pubmed.ncbi.nlm.nih.gov
Cohn J et al. (2003). “Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)”. Eur J Heart Fail5 (5): 659-67. doi:10.1016/S1388-9842(03)00163-6. PMID14607206.